Summary 4-Acetyloxy-N,N-diallyltryptamine (abbreviated as 4-AcO-DALT) is a derivative of tryptamine. It has appeared on the market as a designer drug, but there is limited available information about it. The compound was initially detected in confiscated drug samples in the year 2012. Identifiers IUPAC name CAS Number 1445751-71-2 PubChem CID 119025857 ChemSpider 32078886 UNII 2Z8WS8Z4T1 Chemical …
Summary Methylisopropyllysergamide (MIPLA), also known as lysergic acid methylisopropyl amide, is an analog of LSD discovered initially by Albert Hofmann at Sandoz during the initial research on LSD’s structure-activity relationship. Further investigations into MIPLA have been conducted by a team led by David E. Nichols at Purdue University. MIPLA is a structural isomer of LSD, …
Summary Lysergic acid 2,4-dimethylacetamide (commonly known as LA-SS-Az or LSZ) is a derivative of LSD that was created by a research team led by David E. Nichols at Purdue University. Its development aimed to create a structured analog of LSD, with the diethylamide group constrained within an azetidine ring. This modification was intended to facilitate …
Summary N-Morpholinyllysergamide (LSM-775) is a compound derived from ergine. While it is not as potent as LSD, it is known to induce LSD-like effects within a dosage range of 75 to 700 micrograms, albeit with a shorter duration of action. Notably, LSM-775 is associated with fewer indications of cardiovascular stimulation and peripheral toxicity when compared …
Summary ETH-LAD, scientifically known as 6-ethyl-6-nor-lysergic acid diethylamide, represents an analog of LSD. Alexander Shulgin initially documented its effects on human psychopharmacology in the renowned book TiHKAL. ETH-LAD falls into the category of psychedelic substances akin to LSD but exhibits slightly higher potency, with reported active doses ranging from 20 to 150 micrograms. Notably, ETH-LAD …
Summary AL-LAD, scientifically recognized as 6-allyl-6-nor-LSD, represents a psychedelic substance that shares structural similarities with lysergic acid diethylamide (LSD).[2] This compound is documented in Alexander Shulgin’s book “TiHKAL” (Tryptamines I Have Known And Loved). AL-LAD synthesis begins with nor-LSD as a precursor, incorporating allyl bromide as a critical reactant. Identifiers IUPAC name CAS Number 65527-61-9 …
Summary 1V-LSD, also known colloquially as Valerie, is a psychotropic substance and a research chemical known for its psychedelic effects. This compound is an artificial derivative of natural lysergic acid, found in ergot alkaloids, and serves as an analog of LSD. Until 2022, 1V-LSD was available for purchase online. However, after an amendment to the …
Summary 1P-ETH-LAD, scientifically known as 1-propionyl-6-ethyl-6-nor-lysergic acid diethylamide, is an analog of LSD (lysergic acid diethylamide). This psychedelic compound shares similarities with LSD and belongs to the lysergamide chemical class. Research has indicated that 1P-ETH-LAD can undergo a conversion to ETH-LAD when incubated in human serum, suggesting it may function as a prodrug. Notably, like …
Summary 1P-AL-LAD is a compound derived from lysergic acid diethylamide (LSD) known for its psychedelic properties and association with the designer drug market. It is thought to function as a prodrug for AL-LAD and has demonstrated the ability to induce a head-twitch response in animal research studies. Identifiers IUPAC name PubChem CID 166091990 Chemical and …
Summary 1D-LSD, scientifically known as 1-(1,2-dimethylcyclobutane-1-carbonyl)-lysergic acid diethylamide, is a psychotropic compound classified as a research chemical. It is recognized for its potential to induce psychedelic effects. It is theorized to act as a prodrug for LSD, undergoing metabolic conversion to LSD within the body. Notably, 1D-LSD has replaced 1V-LSD in Germany following the inclusion …
